FDA Approved Drug Treatment for Multiple Sclerosis Patients Now Available at Hackensack Meridian Health Hackensack University Medical Center

Hackensack Meridian Health Hackensack University Medical Center announced a newly approved U.S. Food and Drug Administration drug is now available to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). The drug, Ocrevus, which received FDA approval on March 28th, is the first and only medicine for both relapsing and primary progressive forms of multiple sclerosis.

Click here to view the full article on